Rabourn Amy Zaremba
CIK 1832343 · Head of Fin. Quality Assurance · last filed 2026-04-27
Rabourn Amy Zaremba is a Head of Fin. Quality Assurance who has filed 12 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $8.5K of OCUP on Apr 27, 2026. Across all open-market trades the lifetime net is −$23.3K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OCUP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 120
FARMINGTON HILLS, MI 48335
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. (OCUP) Delisted | Head of Fin. Quality Assurance | 188,671 | $1.17 | $220.7K | -$23.3K | 12 | 2026-04-27 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-27 | Opus Genetics, Inc. (OCUP) Delisted | Sell (S) | −1,641 | -$8.5K | EDGAR |
| 2026-03-18 | Opus Genetics, Inc. (OCUP) Delisted | Sell (S) | −2,816 | -$14.8K | EDGAR |
| 2026-01-26 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +86,500 | $0 | EDGAR |
| 2026-01-21 | Opus Genetics, Inc. (OCUP) Delisted | Tax (F) | −3,390 | -$7.1K | EDGAR |
| 2026-01-13 | Opus Genetics, Inc. (OCUP) Delisted | Tax (F) | −3,950 | -$7.6K | EDGAR |
| 2025-03-17 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +39,500 | $0 | EDGAR |
| 2025-02-06 | Opus Genetics, Inc. (OCUP) Delisted | Tax (F) | −8,190 | -$9.3K | EDGAR |
| 2024-01-22 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2024-01-12 | Opus Genetics, Inc. (OCUP) Delisted | Tax (F) | −3,950 | -$12.9K | EDGAR |
| 2023-01-12 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +46,608 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.